HER2 oncogenic function escapes EGFR tyrosine kinase inhibitors via activation of alternative HER receptors in breast cancer cells.

by Anthony Kong, Véronique Calleja, Pierre Leboucher, Adrian Harris, Peter J Parker, Banafshé Larijani
Published 2008-08-01

The Role of Oxygen in Avascular Tumor Growth.

by David Robert Grimes, Pavitra Kannan, Alan McIntyre, Anthony Kavanagh, Abul Siddiky, Simon Wigfield, Adrian Harris, Mike Partridge
Published 2016-01-01

European Academy of Cancer Sciences – position paper

by Hans‐Olov Adami, Anton Berns, Julio E. Celis, Elisabeth deVries, Alexander Eggermont, Adrian Harris, Harald zur Hausen, Pier Giuseppe Pelicci, Ulrik Ringborg
Published 2018-11-01

17 Activity sensors for noninvasive monitoring of immune response and tumor resistance during immune checkpoint blockade therapy

by Quoc Mac, James Bowen, Hathaichanok Phuengkham, Anirudh Sivakumar, Congmin Xu, Fang-Yi Su, Samuel Stentz, Hyoung Sim, Adrian Harris, Tonia Li, Peng Qiu, Gabriel Kwong
Published 2020-11-01

BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors

by Timo Reisländer, Emilia Puig Lombardi, Florian J. Groelly, Ana Miar, Manuela Porru, Serena Di Vito, Benjamin Wright, Helen Lockstone, Annamaria Biroccio, Adrian Harris, Arturo Londoño-Vallejo, Madalena Tarsounas
Published 2019-07-01

The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer.

by Claire A Walsh, Nina Akrap, Elena Garre, Ylva Magnusson, Hannah Harrison, Daniel Andersson, Emma Jonasson, Svanheidur Rafnsdottir, Hani Choudhry, Francesca Buffa, Jiannis Ragoussis, Anders Ståhlberg, Adrian Harris, Göran Landberg
Published 2020-01-01